A descriptive-comparative study of medications used by older people prior to and following admission to a continuing care facility

Alysha Visram, Donna Wilson

Center for Health Promotion Studies, School of Public Health, University of Alberta, Edmonton, Canada.
Faculty of Nursing, University of Alberta, Edmonton, Canada.

DOI: 10.4236/ojn.2012.21002                

Abstract

Medications are beneficial for curing or managing acute and chronic illnesses. Medications typically have positive outcomes, although older people are prone to drug-related problems. Community-dwelling seniors are at particularly high risk of polypharmacy, as they tend to receive many prescriptions over time and from different care providers. Continuing-care facility admission presents an excellent opportunity for a comprehensive medication review. A research study was conducted to describe and compare medications taken by community-dwelling seniors prior to and following admission to a continuing-care facility. This pilot project involved data being gathered from the charts of deceased residents, as required by a University Health Research Ethics Board, who had been cared for at one large local continuing-care facility. The facility administrators also approved this study, in part to evaluate their policy to conduct a medication review for all new residents within six weeks of entry. This study revealed a slight but statistically significant reduction in the number of medications following this review. Other issues such as medication interactions and required dosage changes were addressed by this medication review. Although this study was confined to one continuing-care facility and a small number of residents, the findings suggest medication reviews would be beneficial upon admission to all continuing-care facilities, and annually perhaps through other means for older persons living in the community.

Keywords

Polypharmacy; Drug Interactions; Older People; Aging; Nursing Homes; Continuing Care; Comparative Research

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Wilson, D. and Truman, C. (2004) Long-term-care residents. Concerns identified by population and care trends. Canadian Journal of Public Health, 95, 382-386.
[2]	McGavock, H. (2004) Prescription related illness—A scandalous pandemic. Journal of Evaluation in Clinical Practice, 10, 491-497. doi:10.1111/j.1365-2753.2003.00471.x
[3]	Frazier, S.C. (2005) Health outcomes and polypharmacy in elderly individuals. Journal of Gerontological Nursing, 31, 4-11.
[4]	Papaioannou, A., Clarke, J., Campbell, G. and Bedard, M. (2000) Assessment of adherence to renal dosing guidelines in long term care facilities. Journal of the American Geriatrics Society, 48, 1470-1473.
[5]	Hastings, S.N. and White, H.K. (2005) Medication review in the nursing home: Can stopping one drug make all the difference? Annals of Long Term Care, 13, 33-35.
[6]	Finkers, F., Maring, J.G., Boersma, F. and Taxis, K. (2007) A study of medication reviews to identify drug- related problems of polypharmacy patients in the Dutch nursing home setting. Journal of Clinical Pharmacy and Therapeutics, 32, 469-476. doi:10.1111/j.1365-2710.2007.00849.x
[7]	Furniss, L., Burns, A., Craig, S.K., Scobie, S., Cooke, J. and Faragher, B. (2000) Effects of pharmacist’s medication review in nursing homes: Randomized controlled trial. British Journal of Psychiatry, 176, 563-567. doi:10.1192/bjp.176.6.563
[8]	Halvorsen, K.H., Ruths, S., Granas, A.G. and Viktil, K.K. (2010) Multidisciplinary intervention to identify and resolve drug-related problems in Nowegian nursing homes. Scandinavian Journal of Primary Health, 28, 82-88. doi:10.3109/02813431003765455
[9]	Khunti, K. and Kinsella, B. (2000) Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents. Age and Ageing, 29, 451-453. doi:10.1093/ageing/29.5.451
[10]	Blue Cross Canada (no date) Enjoy the benefits of good health. http://www.bluecross.ca/
[11]	Salam, A., Mandal, S., Kumar, A. and Almula, A.A. (2008) Polypharmacy: Cure or curse? Quality in Ageing, 9, 24-28. doi:10.1108/14717794200800004
[12]	Zurakowski, T. (2009) The practicalities and pitfalls of polypharmacy. The Nurse Practitioner, 34, 36-41. doi:10.1097/01.NPR.0000348320.38365.59
[13]	Ballentine, N.H. (2008) Polypharmacy in the elderly. Critical Care Nursing, 31, 40-45.
[14]	Tinetti, M.E. (2003) Clinical practice. Preventing falls in elderly persons. New England Journal of Medcine, 348, 42-49. doi:10.1056/NEJMcp020719
[15]	Fulton, M.M. and Allen, E.R. (2005) Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17, 123-132. doi:10.1111/j.1041-2972.2005.0020.x
[16]	Prybys, K., Melville, K., Hanna, J., Gee, A. and Chyka, P. (2002) Polypharmacy in the elderly: Clinical challenges in emergency practice: Part 1 overview, etiology and drug interactions. Emergency Medicine Reports, 23, 145-153.
[17]	Hodgson, N., Freedman, V.A. and Granger, D.A. (2004) Relocation puts elderly nursing home residents at risk of stress, although the stress is short lived. Journal of the American Geriatrics Society, 52, 1856-1862. doi:10.1111/j.1532-5415.2004.52505.x
[18]	Huffman, G.B. (2002) Evaluating and treating unintentional weight loss in the elderly. American Family Physician, 65, 640-654.
[19]	Randall, R.L. and Bruno, S.M. (2006) Can polypharmacy reduction efforts in an ambulatory setting be successful? Clinical Geriatrics, 14, 33-35.
[20]	Kaufman, D., Kelly, J., Rosenberg, L., Anderson, T.E. and Mitchell, A.A. (2002) Recent patterns of medication use in the ambulatory adult population in the United States: The Slone survey. Journal of the American Medical Association, 287, 337-344. doi:10.1001/jama.287.3.337
[21]	Coleman, E.A. (2003) Falling through the cracks: Challenges and opportunities for improving transitional care for persons with continuous complex care needs. Journal of the American Geriatrics Society, 51, 549-555. doi:10.1046/j.1532-5415.2003.51185.x
[22]	Murtaugh, C.M. (2002) Transitions through post-acute and long-term care settings: Patterns of use and outcomes for a national cohort of elders. Medical Care, 40, 227-236. doi:10.1097/00005650-200203000-00006
[23]	Boockvar, K., Fishman, E., Kyriacou, C.K., Monias, A., Gavi, S. and Cortes, T. (2004) Adverse events due to discontinuation in drug use and dose changes in patients transferred between acute and long term care facilities. Archives of Internal Medicine, 164, 545-550. doi:10.1001/archinte.164.5.545
[24]	Dunn, C.M. (2002) Assessing and preventing medication interactions. Home Healthcare Nurse, 20, 105-111. doi:10.1097/00004045-200202000-00008
[25]	Cowan, D., While, A., Roberts, J. and Fitzpatrick, J. (2002) Medicines management in care homes for older people: The nurse’s role. British Journal of Community Nursing, 7, 634-638.
[26]	Stuijt, C.M., Franssen, E.J.F., Egberts, A.C.G. and Hudson, A.H. (2008) Appropriateness of prescribing among elderly patients in a Dutch residential home. Drugs and Aging, 25, 947-954. doi:10.2165/0002512-200825110-00005
[27]	Dilks, S. (2007) The emerging role of the domiciliary pharmacist in Devon. Journal of Integrated Care, 15, 20-25. doi:10.1108/14769018200700035
[28]	Beers, M., Ouslander, J., Rollingher, I., Reuben, D., Brooks, J. and Beck, J. (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. Archives of Internal Medicine, 151, 1825-1832. doi:10.1001/archinte.1991.00400090107019
[29]	Beers, M. (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly: An update. Archives of Internal Medicine, 157, 1531-1537. doi:10.1001/archinte.1997.00440350031003
[30]	Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, R. and Beers, M.H. (2003) Updating he Beers criteria for potentially inappropriate medication use in older adults. Archives of Internal Medicine, 163, 2716-2724. doi:10.1001/archinte.163.22.2716
[31]	McLeod, P.J., Huang, A.R., Tamblyn, R.M. and Gayton, D.C. (1997) Defining inappropriate practices in prescribing for elderly people: A national consensus panel. Canadian Medical Association Journal, 156, 385-391.
[32]	Werder, S.F. and Preskorn, S.H. (2003) Managing polypharmacy: Walking the fine line between help and harm. Journal of Family Practice, 2, 24-36.
[33]	Carlson, J. E. (1996) Perils of polypharmacy: 10 steps to prudent prescribing. Geriatrics, 51, 26-32.
[34]	Statistics Canada (2010) Population estimates and projections. http://www40.statcan.ca/l01/ind01/l3_3867_3433-eng.htm?hili_demo23
[35]	United Nations (2007) World population ageing 2007. http://www.un.org/esa/population/publications/WPA2007/wpp2007.htm